Holen Sie sich die Stockscreener-App
31.89
0.57%
0.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
Published on: 2025-09-05 02:02:16 - Newser
What recovery options are there for TG Therapeutics Inc.2025 Market Outlook & Daily Stock Momentum Reports - Newser
Is TG Therapeutics Inc. stock reversal real or fake2025 Biggest Moves & Daily Risk Controlled Trade Plans - Newser
Real time social sentiment graph for TG Therapeutics IncWeekly Risk Summary & Precise Buy Zone Tips - Newser
What’s the recovery path for long term holders of TG Therapeutics Inc.Trade Risk Report & Daily Profit Maximizing Tips - Newser
Sector ETF performance correlation with TG Therapeutics Inc.Market Risk Analysis & Low Risk High Reward Trade Ideas - Newser
TG Therapeutics CEO to Participate in H.C. Wainwright Global Investment Conference. - AInvest
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
TG Therapeutics: Strategic Innovations and Market Expansion as Catalysts for Investor Optimism - AInvest
Should you wait for a breakout in TG Therapeutics Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser
How institutional ownership impacts TG Therapeutics Inc. stockQuarterly Market Summary & Weekly Stock Breakout Alerts - Newser
Will TG Therapeutics Inc. bounce back from current support2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
Will TG Therapeutics Inc. stock go up in YEARTrade Volume Report & Free Growth Oriented Trading Recommendations - khodrobank.com
What to do if you’re stuck in TG Therapeutics Inc.2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Technical analysis overview for TG Therapeutics Inc. stockJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Can TG Therapeutics Inc. stock outperform in a bear marketDividend Hike & Weekly Breakout Opportunity Watchlist - khodrobank.com
TG Therapeutics (NASDAQ:TGTX) shareholder returns have been fantastic, earning 411% in 3 years - simplywall.st
TG Therapeutics at Cantor Conference: Strategic Growth Insights - Investing.com
Tg Therapeutics shares rise 5.08% intraday after completing a $100 million share repurchase program. - AInvest
TG Therapeutics launches $100M share buybacks (TGTX:NASDAQ) - Seeking Alpha
TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback - uk.finance.yahoo.com
Why Is TG Therapeutics (TGTX) Up 4.7% Since Last Earnings Report? - uk.finance.yahoo.com
Tg Therapeutics shares rise 8.36% intraday after completing $100M stock buyback and authorizing new $100M plan. - AInvest
Using data tools to time your TG Therapeutics Inc. exit2025 Year in Review & Fast Gain Stock Trading Tips - Newser
Ranking TG Therapeutics Inc. among high performing stocks via toolsMarket Risk Summary & Stepwise Trade Execution Plans - Newser
TG Therapeutics Announces Completion of Existing Share - GlobeNewswire
TG Therapeutics, Inc. authorizes a Buyback Plan. - MarketScreener
Tranche Update on TG Therapeutics, Inc.'s Equity Buyback Plan announced on August 6, 2024. - MarketScreener
TG Therapeutics, Inc. announces an Equity Buyback for $100 million worth of its shares. - MarketScreener
How cyclical is TG Therapeutics Inc.’s revenue streamMarket Movers & Verified Swing Trading Watchlists - khodrobank.com
TG Therapeutics Board Authorizes New $100M Share Repurchase Program - Stocktwits
TG Therapeutics’ $100M Share Buyback and Strategic Position in the Anti-CD20 Market - AInvest
TG Therapeutics completes $100 million share buyback, approves new program - Investing.com
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program | TGTX Stock News - GuruFocus
TG Therapeutics Launches New $100 Million Share Buyback Program - MarketScreener
TG Therapeutics Completes $100 Million Share Repurchase Program and Authorizes New $100 Million Repurchase Initiative - Quiver Quantitative
TG Therapeutics completes $100 mln share repurchase program, announces new $100 mln authorization. - AInvest
TG Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Snapshot & Reliable Intraday Trade Alerts - Newser
TG Therapeutics Completes $100M Share Repurchase Program, Authorizes New $100M Program - AInvest
$100M Buyback Complete: TG Therapeutics Doubles Down with Fresh $100M Share Repurchase Authorization - Stock Titan
Sentiment analysis tools applied to TG Therapeutics Inc.July 2025 Momentum & Entry and Exit Point Strategies - Newser
Using fundamentals and technicals on TG Therapeutics Inc2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Analyzing net buyer seller activity in TG Therapeutics Inc.Weekly Trend Recap & Community Trade Idea Sharing - Newser
Can TG Therapeutics Inc. outperform in the next rallyJuly 2025 Movers & Low Risk Growth Stock Ideas - khodrobank.com
Is it too late to sell TG Therapeutics Inc.July 2025 Technicals & Entry Point Strategy Guides - Newser
Using fundamentals and technicals on TG Therapeutics Inc.Quarterly Growth Report & Technical Buy Zone Confirmations - Newser
Why TG Therapeutics Inc. is moving todayBreakout Watch & Daily Chart Pattern Signal Reports - Newser
How to manage a losing position in TG Therapeutics Inc.Portfolio Profit Report & Fast Moving Stock Watchlists - Newser
What is TG Therapeutics Inc.’s market positionQuarterly Portfolio Summary & Verified Trade Idea Suggestions - khodrobank.com
Using Python tools to backtest TG Therapeutics Inc. strategiesTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Merger Talk: Is TG Therapeutics Inc. currently under institutional pressure2025 Market WrapUp & Verified High Yield Trade Plans - khodrobank.com
Real time social sentiment graph for TG Therapeutics Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - Newser
Has TG Therapeutics Inc. formed a bullish divergenceJuly 2025 Outlook & Reliable Intraday Trade Plans - Newser
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):